{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:31:08Z","timestamp":1789047068236,"version":"build-2803163510"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Special Project of Scientific Research of Capital Health Development","award":["2024-2-4194"],"award-info":[{"award-number":["2024-2-4194"]}]},{"name":"Science and Technology Innovation Project of Chinese Academy of Traditional Chinese Medicine","award":["CI2022C002"],"award-info":[{"award-number":["CI2022C002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05362-w","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:53:09Z","timestamp":1782406389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A bibliometric analysis of research trends and future directions in early detection of pancreatic cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Beibei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"3","key":"5362_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"issue":"1","key":"5362_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. Ca. 2025;75(1):10.","journal-title":"Ca"},{"issue":"11","key":"5362_CR3","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913\u201321.","journal-title":"Cancer Res"},{"issue":"11","key":"5362_CR4","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/jnci\/djaa004","volume":"112","author":"AL Blackford","year":"2020","unstructured":"Blackford AL, Canto MI, Klein AP, Hruban RH, Goggins M. Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis. J Natl Cancer Inst. 2020;112(11):1162\u20139. https:\/\/doi.org\/10.1093\/jnci\/djaa004.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"5362_CR5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.hpb.2020.01.001","volume":"22","author":"M Ye","year":"2020","unstructured":"Ye M, Zhang Q, Chen Y, Fu Q, Li X, Bai X, et al. Neoadjuvant chemotherapy for primary resectable pancreatic cancer: a systematic review and meta-analysis. HPB: official J Int Hepato Pancreato Biliary Association. 2020;22(6):821\u201332. https:\/\/doi.org\/10.1016\/j.hpb.2020.01.001.","journal-title":"HPB: official J Int Hepato Pancreato Biliary Association"},{"issue":"3\u20134","key":"5362_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000510343","volume":"106","author":"PC M\u00fcller","year":"2021","unstructured":"M\u00fcller PC, Frey MC, Ruzza CM, Nickel F, Jost C, Gwerder C, et al. Neoadjuvant Chemotherapy in Pancreatic Cancer: An Appraisal of the Current High-Level Evidence. Pharmacology. 2021;106(3\u20134):143\u201353. https:\/\/doi.org\/10.1159\/000510343.","journal-title":"Pharmacology"},{"issue":"7","key":"5362_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/s2468-1253(19)30416-9","volume":"5","author":"SP Pereira","year":"2020","unstructured":"Pereira SP, Oldfield L, Ney A, Hart PA, Keane MG, Pandol SJ, et al. Early detection of pancreatic cancer. lancet Gastroenterol Hepatol. 2020;5(7):698\u2013710.","journal-title":"lancet Gastroenterol Hepatol"},{"issue":"10242","key":"5362_CR8","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/s0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet (London England). 2020;395(10242):2008\u201320. https:\/\/doi.org\/10.1016\/s0140-6736(20)30974-0.","journal-title":"Lancet (London England)"},{"key":"5362_CR9","doi-asserted-by":"publisher","unstructured":"Hruban RH, Maitra A, Kern SE, Goggins M. Precursors to pancreatic cancer. Gastroenterology clinics of North America. 2007;36(4):831\u201349, vi. https:\/\/doi.org\/10.1016\/j.gtc.2007.08.012","DOI":"10.1016\/j.gtc.2007.08.012"},{"issue":"1","key":"5362_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","volume":"69","author":"M Goggins","year":"2020","unstructured":"Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020;69(1):7\u201317. https:\/\/doi.org\/10.1136\/gutjnl-2019-319352.\u00a0","journal-title":"Gut"},{"issue":"4","key":"5362_CR11","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1053\/j.gastro.2020.11.052","volume":"160","author":"JF Fahrmann","year":"2021","unstructured":"Fahrmann JF, Schmidt CM, Mao X, Irajizad E, Loftus M, Zhang J, et al. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection. Gastroenterology. 2021;160(4):1373\u201383.","journal-title":"Gastroenterology"},{"issue":"5","key":"5362_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/jama.2019.10232","volume":"322","author":"DK Owens","year":"2019","unstructured":"Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2019;322(5):438\u201344. https:\/\/doi.org\/10.1001\/jama.2019.10232.\u00a0","journal-title":"JAMA"},{"issue":"3","key":"5362_CR13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1053\/j.gastro.2018.05.035","volume":"155","author":"MI Canto","year":"2018","unstructured":"Canto MI, Almario JA, Schulick RD, Yeo CJ, Klein A, Blackford A, et al. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance. Gastroenterology. 2018;155(3):740\u201351. https:\/\/doi.org\/10.1053\/j.gastro.2018.05.035.\u00a0","journal-title":"Gastroenterology"},{"issue":"5","key":"5362_CR14","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s11605-019-04230-z","volume":"24","author":"MI Canto","year":"2020","unstructured":"Canto MI, Kerdsirichairat T, Yeo CJ, Hruban RH, Shin EJ, Almario JA, et al. Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer. J Gastrointest surgery: official J Soc Surg Aliment Tract. 2020;24(5):1101\u201310. https:\/\/doi.org\/10.1007\/s11605-019-04230-z.\u00a0","journal-title":"J Gastrointest surgery: official J Soc Surg Aliment Tract"},{"key":"5362_CR15","doi-asserted-by":"crossref","unstructured":"Dbouk M, Katona BW, Brand RE, Chak A, Syngal S, Farrell JJ et al. The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2022;40(28):3257\u201366. doi: 10.1200\/jco.22.00298.","DOI":"10.1200\/JCO.22.00298"},{"key":"5362_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jbusres.2021.04.070","volume":"133","author":"N Donthu","year":"2021","unstructured":"Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM. How to conduct a bibliometric analysis: An overview and guidelines. J Bus Res. 2021;133:285\u201396.","journal-title":"J Bus Res"},{"issue":"5","key":"5362_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4240\/wjgs.v9.i5.127","volume":"9","author":"K Ivanov","year":"2017","unstructured":"Ivanov K, Donev I. International scientific communications in the field of colorectal tumour markers. World J Gastrointest Surg. 2017;9(5):127.","journal-title":"World J Gastrointest Surg"},{"key":"5362_CR18","doi-asserted-by":"publisher","first-page":"1068747","DOI":"10.3389\/fonc.2023.1068747","volume":"13","author":"S Liu","year":"2023","unstructured":"Liu S, Zhang N, Hao Y, Li P. Global research trends of endoscope in early gastric cancer: A bibliometric and visualized analysis study over past 20 years. Front Oncol. 2023;13:1068747.","journal-title":"Front Oncol"},{"key":"5362_CR19","doi-asserted-by":"publisher","first-page":"832385","DOI":"10.3389\/fonc.2022.832385","volume":"12","author":"K Wang","year":"2022","unstructured":"Wang K, Herr I. Machine-learning-based bibliometric analysis of pancreatic cancer research over the past 25 years. Front Oncol. 2022;12:832385.","journal-title":"Front Oncol"},{"key":"5362_CR20","doi-asserted-by":"crossref","unstructured":"Wu BB, Liu Y, Zhang XX, Luo D, Wang XJ, Qiao C et al. A bibliometric insight into nanomaterials in vaccine: trends, collaborations, and future avenues. Front Immunol. 2024;15. doi: 10.3389\/fimmu.2024.1420216.","DOI":"10.3389\/fimmu.2024.1420216"},{"key":"5362_CR21","doi-asserted-by":"crossref","unstructured":"Wu BB, Luo D, Wang XJ, Qiao C, Li R, Liu J. The global trends and distribution in tumor-infiltrating lymphocytes over the past 49 years: bibliometric and visualized analysis. Front Immunol. 2025;15. doi: 10.3389\/fimmu.2024.1511866.","DOI":"10.3389\/fimmu.2024.1511866"},{"key":"5362_CR22","doi-asserted-by":"publisher","unstructured":"Wu BB, Zhang T, Dai N, Luo D, Wang XJ, Qiao C, et al. Global research trends in tongue cancer from 2000 to 2022: bibliometric and visualized analysis. Clin Oral Invest. 2024;28(2). https:\/\/doi.org\/10.1007\/s00784-024-05516-6.\u00a0","DOI":"10.1007\/s00784-024-05516-6"},{"issue":"6","key":"5362_CR23","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.32604\/or.2025.059290","volume":"33","author":"CC Zhang","year":"2025","unstructured":"Zhang CC, Liu Y, Chen ZH, Liu Y, Mao QY, Zhang G, et al. Current status, hotspots, and trends in cancer prevention, screening, diagnosis, treatment, and rehabilitation: A bibliometric analysis. Oncol Res. 2025;33(6):1437\u201358.","journal-title":"Oncol Res"},{"issue":"46","key":"5362_CR24","doi-asserted-by":"publisher","first-page":"16569","DOI":"10.1073\/pnas.0507655102","volume":"102","author":"JE Hirsch","year":"2005","unstructured":"Hirsch JE. An index to quantify an individual\u2019s scientific research output. Proc Natl Acad Sci USA. 2005;102(46):16569\u201372. https:\/\/doi.org\/10.1073\/pnas.0507655102.\u00a0","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"5362_CR25","first-page":"736","volume":"35","author":"AF Choudhri","year":"2015","unstructured":"Choudhri AF, Siddiqui A, Khan NR, Cohen HL. Underst Bibliometric Parameters Anal. 2015;35(3):736\u201346.","journal-title":"Underst Bibliometric Parameters Anal"},{"issue":"5","key":"5362_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00000478-200105000-00003","volume":"25","author":"RH Hruban","year":"2001","unstructured":"Hruban RH, Adsay NV, Albores\u2013Saavedra J, Compton C, Garrett ES, Goodman SN, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001;25(5):579\u201386.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"5362_CR27","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/01.pas.0000126675.59108.80","volume":"28","author":"RH Hruban","year":"2004","unstructured":"Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28(8):977\u201387.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"5362_CR28","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/00000478-200407000-00001","volume":"28","author":"NV Adsay","year":"2004","unstructured":"Adsay NV, Merati K, Basturk O, Iacobuzio-Donahue C, Levi E, Cheng JD, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an intestinal pathway of carcinogenesis in the pancreas. Am J Surg Pathol. 2004;28(7):839\u201348.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"5362_CR29","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s00428-005-0039-7","volume":"447","author":"T Furukawa","year":"2005","unstructured":"Furukawa T, Kl\u00f6ppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447(5):794\u20139.","journal-title":"Virchows Arch"},{"issue":"12","key":"5362_CR30","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","volume":"39","author":"O Basturk","year":"2015","unstructured":"Basturk O, Hong SM, Wood LD, Adsay NV, Albores-Saavedra J, Biankin AV, et al. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Am J Surg Pathol. 2015;39(12):1730\u201341.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"5362_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/00000658-200109000-00005","volume":"234","author":"TA Sohn","year":"2001","unstructured":"Sohn TA, Yeo CJ, Cameron JL, Iacobuzio-Donahue CA, Hruban RH, Lillemoe KD. Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg. 2001;234(3):313\u201322.","journal-title":"Ann Surg"},{"issue":"6","key":"5362_CR32","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1097\/01.sla.0000128306.90650.aa","volume":"239","author":"TA Sohn","year":"2004","unstructured":"Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239(6):788\u201399.","journal-title":"Ann Surg"},{"issue":"5","key":"5362_CR33","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/01.sla.0000124386.54496.15","volume":"239","author":"R Salvia","year":"2004","unstructured":"Salvia R, Fern\u00e1ndez-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239(5):678\u201387.","journal-title":"Ann Surg"},{"issue":"1","key":"5362_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1053\/j.gastro.2007.05.010","volume":"133","author":"JR Rodriguez","year":"2007","unstructured":"Rodriguez JR, Salvia R, Crippa S, Warshaw AL, Bassi C, Falconi M, et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology. 2007;133(1):72\u20139.","journal-title":"Gastroenterology"},{"issue":"7","key":"5362_CR35","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1001\/archsurg.143.7.639","volume":"143","author":"T Schnelldorfer","year":"2008","unstructured":"Schnelldorfer T, Sarr MG, Nagorney DM, Zhang L, Smyrk TC, Qin R, et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg. 2008;143(7):639\u201346.","journal-title":"Arch Surg"},{"issue":"4","key":"5362_CR36","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/SLA.0b013e318155a9e5","volume":"246","author":"CM Schmidt","year":"2007","unstructured":"Schmidt CM, White PB, Waters JA, Yiannoutsos CT, Cummings OW, Baker M, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007;246(4):644\u201354.","journal-title":"Ann Surg"},{"issue":"92","key":"5362_CR37","doi-asserted-by":"publisher","first-page":"ra9266","DOI":"10.1126\/scitranslmed.3002543","volume":"3","author":"J Wu","year":"2011","unstructured":"Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, Eshleman JR, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3(92):ra9266\u20139266.","journal-title":"Sci Transl Med"},{"issue":"6","key":"5362_CR38","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1053\/j.gastro.2015.07.041","volume":"149","author":"S Springer","year":"2015","unstructured":"Springer S, Wang Y, Dal Molin M, Masica DL, Jiao Y, Kinde I, et al. A combination of molecular markers and clinical features improve the classification of pancreatic cysts. Gastroenterology. 2015;149(6):1501\u201310.","journal-title":"Gastroenterology"},{"key":"5362_CR39","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.2147\/JPR.S340961","volume":"14","author":"L Huang","year":"2021","unstructured":"Huang L, Xu G, He J, Tian H, Zhou Z, Huang F, et al. Bibliometric Analysis of Functional Magnetic Resonance Imaging Studies on Acupuncture Analgesia Over the Past 20 Years. J pain Res. 2021;14:3773\u201389.","journal-title":"J pain Res"},{"issue":"4","key":"5362_CR40","doi-asserted-by":"publisher","first-page":"e267837","DOI":"10.1001\/jamanetworkopen.2026.7837","volume":"9","author":"C Mohindroo","year":"2026","unstructured":"Mohindroo C, Thomas A, Incidence. Mortality, and Federal Research Funding by Cancer Type in the US. JAMA Netw Open. 2026;9(4):e267837.","journal-title":"JAMA Netw Open"},{"issue":"16","key":"5362_CR41","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1158\/1078-0432.CCR-14-0513","volume":"20","author":"AD Singhi","year":"2014","unstructured":"Singhi AD, Nikiforova MN, Fasanella KE, McGrath KM, Pai RK, Ohori NP, et al. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts. Clin Cancer Res. 2014;20(16):4381\u20139.","journal-title":"Clin Cancer Res"},{"key":"5362_CR42","doi-asserted-by":"publisher","unstructured":"Ahmed S, Bradshaw AD, Gera S, Dewan MZ, Xu R. The TGF-\u03b2\/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance. J Clin Med. 2017;6(1). https:\/\/doi.org\/10.3390\/jcm6010005.\u00a0","DOI":"10.3390\/jcm6010005"},{"key":"5362_CR43","doi-asserted-by":"publisher","first-page":"1520717","DOI":"10.3389\/fonc.2025.1520717","volume":"15","author":"M Cox","year":"2025","unstructured":"Cox M, Vitello D, Chawla A. Translating the multifaceted use of liquid biopsy to management of early disease in pancreatic adenocarcinoma. Front Oncol. 2025;15:1520717.","journal-title":"Front Oncol"},{"issue":"5","key":"5362_CR44","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.gie.2020.12.014","volume":"93","author":"TR McCarty","year":"2021","unstructured":"McCarty TR, Paleti S, Rustagi T. Molecular analysis of EUS-acquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93(5):1019\u201333.","journal-title":"Gastrointest Endosc"},{"key":"5362_CR45","doi-asserted-by":"crossref","unstructured":"Yanala UR, Martos MP, Dickey EM, Corona AM, Ezenwajiaku N, Pizzolato JF, et al. Utility of circulating tumor DNA (ctDNA) for the detection of minimal residual disease (MRD) after curative-intent therapy for patients with localized pancreatic adenocarcinoma (PDAC): A single institution series and meta-analysis. American Society of Clinical Oncology; 2024.","DOI":"10.1200\/JCO.2024.42.3_suppl.695"},{"issue":"2","key":"5362_CR46","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ueg2.12360","volume":"11","author":"IS Ibrahim","year":"2023","unstructured":"Ibrahim IS, Vasen HFA, Wasser M, Feshtali S, Bonsing BA, Morreau H, et al. Cost-effectiveness of pancreas surveillance: The CDKN2A-p16-Leiden cohort. United Eur Gastroenterol J. 2023;11(2):163\u201370. https:\/\/doi.org\/10.1002\/ueg2.12360.\u00a0","journal-title":"United Eur Gastroenterol J"},{"issue":"2","key":"5362_CR47","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1200\/OP.23.00495","volume":"20","author":"MLB Peters","year":"2024","unstructured":"Peters MLB, Eckel A, Seguin CL, Davidi B, Howard DH, Knudsen AB, et al. Cost-effectiveness analysis of screening for pancreatic cancer among high-risk populations. JCO Oncol Pract. 2024;20(2):278\u201390.","journal-title":"JCO Oncol Pract"},{"key":"5362_CR48","doi-asserted-by":"publisher","unstructured":"Wang L, Scott FI, Boursi B, Reiss KA, Williams S, Glick H et al. Cost-Effectiveness of a Risk-Tailored Pancreatic Cancer Early Detection Strategy Among Patients With New-Onset Diabetes. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2022;20(9):1997\u20132004. https:\/\/doi.org\/10.1016\/j.cgh.2021.10.037.\u00a0","DOI":"10.1016\/j.cgh.2021.10.037"},{"issue":"10","key":"5362_CR49","doi-asserted-by":"publisher","first-page":"e2538031","DOI":"10.1001\/jamanetworkopen.2025.38031","volume":"8","author":"I Stefanova","year":"2025","unstructured":"Stefanova I, Thompson N, Oldfield L, Stott M, Hanson R, Palmer D, et al. Cost-effectiveness of biomarker-associated early pancreatic cancer detection in new-onset diabetes. JAMA Netw open. 2025;8(10):e2538031.","journal-title":"JAMA Netw open"},{"issue":"1","key":"5362_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/cancers16010086","volume":"16","author":"I Anez-Bruzual","year":"2023","unstructured":"Anez-Bruzual I, Coughlin S, Clay D, Heiman J, Dungan M, Weber M, et al. Assessment of the psychosocial impact of pancreatic cancer surveillance in high-risk individuals. Cancers. 2023;16(1):86.","journal-title":"Cancers"},{"issue":"1","key":"5362_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/eus.eus_25_18","volume":"8","author":"IM Cazacu","year":"2019","unstructured":"Cazacu IM, Chavez AAL, Saftoiu A, Bhutani MS. Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: A systematic review. Endoscopic ultrasound. 2019;8(1):17\u201324.","journal-title":"Endoscopic ultrasound"},{"issue":"18","key":"5362_CR52","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.3390\/cancers17183014","volume":"17","author":"V Marinelli","year":"2025","unstructured":"Marinelli V, Mazzi MA, Maggioni O, Venturini E, Rimondini M, Milella M, et al. Assessment of Psychological Burden in Individuals with Hereditary Risk of Pancreatic Cancer Under Surveillance: Evaluation of Distress 3 Years After Enrollment. Cancers. 2025;17(18):3014.","journal-title":"Cancers"},{"key":"5362_CR53","volume-title":"U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Screening for Pancreatic Cancer: A Systematic Evidence Review for the US Preventive Services Task Force","author":"NB Henrikson","year":"2019","unstructured":"Henrikson NB, Bowles EJA, Blasi PR, Morrison CC, Nguyen M, Pillarisetty VG, et al. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Screening for Pancreatic Cancer: A Systematic Evidence Review for the US Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2019."},{"key":"5362_CR54","doi-asserted-by":"crossref","unstructured":"Pedro BA, Wood LD. Early neoplastic lesions of the pancreas: initiation, progression, and opportunities for precancer interception. J Clin Investig. 2025;135(14).","DOI":"10.1172\/JCI191937"},{"issue":"1","key":"5362_CR55","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1053\/j.gastro.2020.03.088","volume":"159","author":"HR Aslanian","year":"2020","unstructured":"Aslanian HR, Lee JH, Canto MI, AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals. Expert Rev Gastroenterol. 2020;159(1):358\u201362. https:\/\/doi.org\/10.1053\/j.gastro.2020.03.088.","journal-title":"Expert Rev Gastroenterol"},{"issue":"1","key":"5362_CR56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/s1470-2045(08)70337-1","volume":"10","author":"R Pannala","year":"2009","unstructured":"Pannala R, Basu A, Petersen GM, Chari ST. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol. 2009;10(1):88\u201395.","journal-title":"Lancet Oncol"},{"issue":"5","key":"5362_CR57","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.gie.2021.12.001","volume":"95","author":"MS Sawhney","year":"2022","unstructured":"Sawhney MS, Calderwood AH, Thosani NC, Rebbeck TR, Wani S, Canto MI, et al. ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations. Gastrointest Endosc. 2022;95(5):817\u201326. https:\/\/doi.org\/10.1016\/j.gie.2021.12.001.\u00a0","journal-title":"Gastrointest Endosc"},{"key":"5362_CR58","unstructured":"Genetic\/Familial High-Risk Assessment. Breast, Ovarian, Pancreatic, and Prostate: National Comprehensive Cancer Network; [2026 Apr 04]. Available from: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=2&id=1545"},{"issue":"2","key":"5362_CR61","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","volume":"24","author":"T Ohtsuka","year":"2024","unstructured":"Ohtsuka T, Fernandez-del Castillo C, Furukawa T, Hijioka S, Jang J-Y, Lennon AM, et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024;24(2):255\u201370.","journal-title":"Pancreatology"},{"issue":"4","key":"5362_CR62","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1053\/j.gastro.2023.06.022","volume":"165","author":"G Marchegiani","year":"2023","unstructured":"Marchegiani G, Pollini T, Burelli A, Han Y, Jung H-S, Kwon W, et al. Surveillance for presumed BD-IPMN of the pancreas: stability, size, and age identify targets for discontinuation. Gastroenterology. 2023;165(4):1016\u201324. e5.","journal-title":"Gastroenterology"},{"issue":"1","key":"5362_CR63","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1053\/j.gastro.2019.08.032","volume":"158","author":"H Oyama","year":"2020","unstructured":"Oyama H, Tada M, Takagi K, Tateishi K, Hamada T, Nakai Y, et al. Long-term risk of malignancy in branch-duct intraductal papillary mucinous neoplasms. Gastroenterology. 2020;158(1):226\u201337. e5.","journal-title":"Gastroenterology"},{"key":"5362_CR64","doi-asserted-by":"publisher","first-page":"e2500696","DOI":"10.1200\/PO-25-00696","volume":"9","author":"A Manam","year":"2025","unstructured":"Manam A, Everett JN, Haraldsdottir S, Hart PA, Kaul V, Klute K, et al. Areas of Uncertainty in Pancreatic Cancer Surveillance: A Survey Across the International Pancreatic Cancer Early Detection (PRECEDE) Consortium. JCO precision Oncol. 2025;9:e2500696.","journal-title":"JCO precision Oncol"},{"issue":"17","key":"5362_CR65","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1200\/jco.2015.64.0730","volume":"34","author":"H Vasen","year":"2016","unstructured":"Vasen H, Ibrahim I, Ponce CG, Slater EP, Matth\u00e4i E, Carrato A, et al. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers. J Clin oncology: official J Am Soc Clin Oncol. 2016;34(17):2010\u20139. https:\/\/doi.org\/10.1200\/jco.2015.64.0730.\u00a0","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"issue":"1","key":"5362_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/jnci\/djy090","volume":"111","author":"VW Setiawan","year":"2019","unstructured":"Setiawan VW, Stram DO, Porcel J, Chari ST, Maskarinec G, Le Marchand L, et al. Pancreatic Cancer Following Incident Diabetes in African Americans and Latinos: The Multiethnic Cohort. J Natl Cancer Inst. 2019;111(1):27\u201333. https:\/\/doi.org\/10.1093\/jnci\/djy090.\u00a0","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"5362_CR67","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","volume":"24","author":"T Ohtsuka","year":"2024","unstructured":"Ohtsuka T, Fernandez-del Castillo C, Furukawa T, Hijioka S, Jang JY, Lennon AM, et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024;24(2):255\u201370.","journal-title":"Pancreatology"},{"issue":"12","key":"5362_CR68","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.cgh.2024.05.043","volume":"22","author":"T Hamada","year":"2024","unstructured":"Hamada T, Oyama H, Tange S, Hakuta R, Ishigaki K, Kanai S, et al. The Revised Kyoto Criteria and Risk of Malignancy Among Patients With Intraductal Papillary Mucinous Neoplasms. Clin Gastroenterol Hepatol. 2024;22(12):2413\u2013e2318. https:\/\/doi.org\/10.1016\/j.cgh.2024.05.043.\u00a0","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"5362_CR69","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.gastro.2018.05.023","volume":"155","author":"A Sharma","year":"2018","unstructured":"Sharma A, Kandlakunta H, Nagpal SJS, Feng Z, Hoos W, Petersen GM, et al. Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes. Gastroenterology. 2018;155(3):730\u2013e93. https:\/\/doi.org\/10.1053\/j.gastro.2018.05.023","journal-title":"Gastroenterology"},{"issue":"5","key":"5362_CR70","doi-asserted-by":"publisher","first-page":"451","DOI":"10.6004\/jnccn.2020.7798","volume":"20","author":"NR Schwartz","year":"2021","unstructured":"Schwartz NR, Matrisian LM, Shrader EE, Feng Z, Chari S, Roth JA. Potential cost-effectiveness of risk-based pancreatic cancer screening in patients with new-onset diabetes. J Natl Compr Canc Netw. 2021;20(5):451\u20139.","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"5362_CR71","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1053\/j.gastro.2021.10.014","volume":"162","author":"KA Overbeek","year":"2022","unstructured":"Overbeek KA, Goggins MG, Dbouk M, Levink IJM, Koopmann BDM, Chuidian M, et al. Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals. Gastroenterology. 2022;162(3):772\u2013e854. https:\/\/doi.org\/10.1053\/j.gastro.2021.10.014.\u00a0","journal-title":"Gastroenterology"},{"key":"5362_CR72","doi-asserted-by":"publisher","unstructured":"Wood LD, Canto MI, Jaffee EM, Simeone DM. Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment. Gastroenterology. 2022;163(2):386\u2013402. https:\/\/doi.org\/10.1053\/j.gastro.2022.03.056.\u00a0","DOI":"10.1053\/j.gastro.2022.03.056"},{"key":"5362_CR73","doi-asserted-by":"publisher","unstructured":"Grunvald MW, Jacobson RA, Kuzel TM, Pappas SG, Masood A. Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer. International journal of molecular sciences. 2020;21(20). https:\/\/doi.org\/10.3390\/ijms21207651.\u00a0","DOI":"10.3390\/ijms21207651"},{"issue":"38","key":"5362_CR74","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1073\/pnas.1704961114","volume":"114","author":"JD Cohen","year":"2017","unstructured":"Cohen JD, Javed AA, Thoburn C, Wong F, Tie J, Gibbs P, et al. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. Proc Natl Acad Sci USA. 2017;114(38):10202\u20137. https:\/\/doi.org\/10.1073\/pnas.1704961114.\u00a0","journal-title":"Proc Natl Acad Sci USA"},{"key":"5362_CR75","doi-asserted-by":"publisher","unstructured":"Xing H, Wang J, Wang Y, Tong M, Hu H, Huang C et al. Diagnostic Value of CA 19\u2009\u2013\u20099 and Carcinoembryonic Antigen for Pancreatic Cancer: A Meta-Analysis. Gastroenterol Res Pract. 2018;2018:8704751. https:\/\/doi.org\/10.1155\/2018\/8704751.\u00a0","DOI":"10.1155\/2018\/8704751"},{"issue":"5","key":"5362_CR76","doi-asserted-by":"publisher","first-page":"e0322720","DOI":"10.1371\/journal.pone.0322720","volume":"20","author":"Z Zheng","year":"2025","unstructured":"Zheng Z, Lu Z, Yan F, Song Y. The role of novel biomarkers in the early diagnosis of pancreatic cancer: A systematic review and meta-analysis. PLoS ONE. 2025;20(5):e0322720. https:\/\/doi.org\/10.1371\/journal.pone.0322720.\u00a0","journal-title":"PLoS ONE"},{"issue":"10","key":"5362_CR77","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1158\/2767-9764.CRC-22-0190","volume":"2","author":"LE Kane","year":"2022","unstructured":"Kane LE, Mellotte GS, Mylod E, O\u2019Brien RM, O\u2019Connell F, Buckley CE, et al. Diagnostic accuracy of blood-based biomarkers for pancreatic cancer: a systematic review and meta-analysis. Cancer Res Commun. 2022;2(10):1229\u201343.","journal-title":"Cancer Res Commun"},{"issue":"4","key":"5362_CR78","first-page":"459","volume":"106","author":"NJ Pyzocha","year":"2022","unstructured":"Pyzocha NJ. Galleri Test for the Detection of Cancer. Am Fam Physician. 2022;106(4):459\u201360.","journal-title":"Am Fam Physician"},{"issue":"6378","key":"5362_CR79","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen JD, Li L, Wang YX, Thoburn C, Afsari B, Danilova L, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018;359(6378):926\u2013. https:\/\/doi.org\/10.1126\/science.aar3247.","journal-title":"Science"},{"key":"5362_CR80","unstructured":"Newswire PGRAIL, Submits. FDA Premarket Approval Application for the Galleri\u00ae Multi-Cancer Early Detection Test 2026 [2026 Apr 05]. Available from: https:\/\/www.prnewswire.com\/news\/grail%2C-inc.\/"},{"key":"5362_CR81","unstructured":"FOUNDATION pc. MULTI-CANCER EARLY DETECTION Coverage and Legislation [2026 Apr 05]. Available from: https:\/\/preventcancer.org\/policy-advocacy\/multi-cancer-early-detection\/coverage-and-legislation\/"},{"key":"5362_CR82","unstructured":"Lyss AP. Blood Test Shows Promise for Detecting Cancers Without Approved Screening Tests. Cancer Therapy Advisor. 2022:NA\u2013NA."},{"key":"5362_CR83","doi-asserted-by":"crossref","unstructured":"Cohen JD, Javed AA, Thoburn C, Wong F, Tie J, Gibbs P et al. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. Proceedings of the National Academy of Sciences. 2017;114(38):10202\u20137.","DOI":"10.1073\/pnas.1704961114"},{"issue":"9","key":"5362_CR84","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1158\/1078-0432.CCR-20-0235","volume":"27","author":"S Majumder","year":"2021","unstructured":"Majumder S, Taylor WR, Foote PH, Berger CK, Wu CW, Mahoney DW, et al. High detection rates of pancreatic cancer across stages by plasma assay of novel methylated DNA markers and CA19-9. Clin Cancer Res. 2021;27(9):2523\u201332.","journal-title":"Clin Cancer Res"},{"issue":"785","key":"5362_CR85","doi-asserted-by":"publisher","first-page":"eadq3110","DOI":"10.1126\/scitranslmed.adq3110","volume":"17","author":"JL Montoya Mira","year":"2025","unstructured":"Montoya Mira JL, Quentel A, Patel RK, Keith D, Sousa M, Minnier J, et al. Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay. Sci Transl Med. 2025;17(785):eadq3110.","journal-title":"Sci Transl Med"},{"key":"5362_CR86","doi-asserted-by":"crossref","unstructured":"Krusen BM, Gimotty PA, Donahue G, Till JE, Yin M, Carlson EE et al. Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobin Receptor (PIGR). Clin Cancer Res. 2026:OF1\u201314.","DOI":"10.1158\/1078-0432.31353179"},{"issue":"2","key":"5362_CR87","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1158\/1940-6207.Capr-20-0403","volume":"14","author":"S Udgata","year":"2021","unstructured":"Udgata S, Takenaka N, Bamlet WR, Oberg AL, Yee SS, Carpenter EL, et al. THBS2\/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement. Cancer Prev Res (Phila). 2021;14(2):223\u201332. https:\/\/doi.org\/10.1158\/1940-6207.Capr-20-0403.\u00a0","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"5362_CR88","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1245\/s10434-025-18848-8","volume":"33","author":"AD Singhi","year":"2026","unstructured":"Singhi AD, Wald AI, Smith K, Wolkenstein L, Bubar RD, Diaz-Aragon R, et al. PancreaSeq Genomic Classifier (PancreaSeq GC) Improves Pancreatic Cyst Classification and Detection of Advanced Neoplasia: A Multi-institutional Validation Study. Ann Surg Oncol. 2026;33(4):2865\u201375. https:\/\/doi.org\/10.1245\/s10434-025-18848-8. Epub 20251212.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"5362_CR89","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.gie.2021.04.025","volume":"94","author":"TR McCarty","year":"2021","unstructured":"McCarty TR, Garg R, Rustagi T. Pancreatic cyst fluid glucose in differentiating mucinous from nonmucinous pancreatic cysts: a systematic review and meta-analysis. Gastrointest Endosc. 2021;94(4):698\u2013712. e6.","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"5362_CR90","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","volume":"31","author":"MC Liu","year":"2020","unstructured":"Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Annals oncology: official J Eur Soc Med Oncol. 2020;31(6):745\u201359.","journal-title":"Annals oncology: official J Eur Soc Med Oncol"},{"issue":"1","key":"5362_CR91","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13148-019-0650-0","volume":"11","author":"MAL Eissa","year":"2019","unstructured":"Eissa MAL, Lerner L, Abdelfatah E, Shankar N, Canner JK, Hasan NM, et al. Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood. Clin epigenetics. 2019;11(1):59. https:\/\/doi.org\/10.1186\/s13148-019-0650-0.\u00a0","journal-title":"Clin epigenetics"},{"key":"5362_CR92","doi-asserted-by":"publisher","unstructured":"Guler GD, Ning Y, Ku CJ, Phillips T, McCarthy E, Ellison CK et al. Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA. Nature communications. 2020;11(1):5270. https:\/\/doi.org\/10.1038\/s41467-020-18965-w \u00a0","DOI":"10.1038\/s41467-020-18965-w"},{"issue":"5","key":"5362_CR93","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.cgh.2024.07.048","volume":"23","author":"MM Engels","year":"2025","unstructured":"Engels MM, Berger CK, Mahoney DW, Hoogenboom SA, Sarwal D, Klatte DC, et al. Multimodal pancreatic cancer detection using methylated DNA biomarkers in pancreatic juice and plasma CA 19\u2009\u2013\u20099: a prospective multicenter study. Clin Gastroenterol Hepatol. 2025;23(5):766\u201375.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7559","key":"5362_CR94","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature14581","volume":"523","author":"SA Melo","year":"2015","unstructured":"Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523(7559):177\u201382. https:\/\/doi.org\/10.1038\/nature14581.\u00a0","journal-title":"Nature"},{"issue":"16","key":"5362_CR95","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.7150\/jca.32052","volume":"10","author":"Y Liu","year":"2019","unstructured":"Liu Y, Feng W, Liu W, Kong X, Li L, He J, et al. Circulating lncRNA ABHD11-AS1 serves as a biomarker for early pancreatic cancer diagnosis. J Cancer. 2019;10(16):3746\u201356. https:\/\/doi.org\/10.7150\/jca.32052.\u00a0","journal-title":"J Cancer"},{"issue":"12","key":"5362_CR96","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1038\/s41591-023-02640-w","volume":"29","author":"K Cao","year":"2023","unstructured":"Cao K, Xia Y, Yao J, Han X, Lambert L, Zhang T, et al. Large-scale pancreatic cancer detection via non-contrast CT and deep learning. Nat Med. 2023;29(12):3033\u201343.","journal-title":"Nat Med"},{"key":"5362_CR97","doi-asserted-by":"crossref","unstructured":"Jia K, Kundrot S, Palchuk MB, Warnick J, Haapala K, Kaplan ID et al. A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data. Ebiomedicine. 2023;98. doi: 10.1016\/j.ebiom.2023.104888.","DOI":"10.1016\/j.ebiom.2023.104888"},{"issue":"5","key":"5362_CR98","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41591-023-02332-5","volume":"29","author":"D Placido","year":"2023","unstructured":"Placido D, Yuan B, Hjaltelin JX, Zheng C, Haue AD, Chmura PJ, et al. A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories. Nat Med. 2023;29(5):1113\u201322.","journal-title":"Nat Med"},{"key":"5362_CR99","doi-asserted-by":"publisher","first-page":"106659","DOI":"10.1016\/j.cct.2021.106659","volume":"113","author":"ST Chari","year":"2022","unstructured":"Chari ST, Maitra A, Matrisian LM, Shrader EE, Wu BU, Kambadakone A, et al. Early detection initiative: a randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma. Contemp Clin Trials. 2022;113:106659.","journal-title":"Contemp Clin Trials"},{"key":"5362_CR101","doi-asserted-by":"crossref","unstructured":"Sudhakara Prasad K, Cao X, Gao N, Jin Q, Sanjay ST, Henao-Pabon G et al. A Low-Cost Nanomaterial-based Electrochemical Immunosensor on Paper for High-Sensitivity Early Detection of Pancreatic Cancer. Sens actuators B Chem. 2020;305. doi: 10.1016\/j.snb.2019.127516.","DOI":"10.1016\/j.snb.2019.127516"},{"issue":"3","key":"5362_CR102","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1021\/acssensors.2c02105","volume":"8","author":"AN Masterson","year":"2023","unstructured":"Masterson AN, Chowdhury NN, Fang Y, Yip-Schneider MT, Hati S, Gupta P, et al. Amplification-Free, High-Throughput Nanoplasmonic Quantification of Circulating MicroRNAs in Unprocessed Plasma Microsamples for Earlier Pancreatic Cancer Detection. ACS Sens. 2023;8(3):1085\u2013100. https:\/\/doi.org\/10.1021\/acssensors.2c02105.\u00a0","journal-title":"ACS Sens"},{"issue":"12","key":"5362_CR103","doi-asserted-by":"publisher","first-page":"11384","DOI":"10.1021\/acsnano.3c00674","volume":"17","author":"Z Yu","year":"2023","unstructured":"Yu Z, Yang Y, Fang W, Hu P, Liu Y, Shi J. Dual Tumor Exosome Biomarker Co-recognitions Based Nanoliquid Biopsy for the Accurate Early Diagnosis of Pancreatic Cancer. ACS Nano. 2023;17(12):11384\u201395. https:\/\/doi.org\/10.1021\/acsnano.3c00674.\u00a0","journal-title":"ACS Nano"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05362-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05362-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05362-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:02:40Z","timestamp":1789045360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05362-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5362"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05362-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1323"}}